Recombinant COVID-19 Variant Vaccine (Sf9 cell)

· WestVac Biopharma Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Recombinant COVID-19 Variant Vaccine (Sf9 cell), covering 2024-07-24 to 2024-07-24. Get the full timeline:

Most recent: Clinical Trial Update: Phase II Clinical Trial of Recombinant COVID-19 Variant Vaccine (Sf9 Cell) [Phase 2]